MoonLake Immunotherapeutics (MLTX) Change in Cash (2021 - 2026)

MoonLake Immunotherapeutics' Change in Cash history runs 6 years deep, the most recent figure standing at -$36.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 139.53% year-over-year to -$36.0 million; the TTM figure through Mar 2026 stood at $26.9 million (up 114.41% YoY), while the FY2025 annual figure was $154.1 million, up 156.91% from the prior year.
• Change in Cash was -$36.0 million for Q1 2026 at MoonLake Immunotherapeutics, down from -$16.2 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $451.7 million in Q2 2023 to a low of -$195.2 million in Q4 2024.
• Historically, Change in Cash has averaged $17.1 million across 5 years, with a median of $7.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Change in Cash plunged 3259.8% in 2022, then soared 7928.12% in 2023.
• A 5-year view of Change in Cash shows it stood at -$1.7 million in 2022, then jumped by 7928.12% to $133.0 million in 2023, then slumped by 246.79% to -$195.2 million in 2024, then soared by 91.69% to -$16.2 million in 2025, then plunged by 122.13% to -$36.0 million in 2026.
• The last three Change in Cash figures came in at -$36.0 million (Q1 2026), -$16.2 million (Q4 2025), and $44.1 million (Q3 2025), per Business Quant data.